These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8587288

  • 1. Cyclosporine-induced renal dysfunction in experimental animals and humans.
    Remuzzi G, Perico N.
    Kidney Int Suppl; 1995 Dec; 52():S70-4. PubMed ID: 8587288
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A, Druskis V, Laurinavicius A.
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [Abstract] [Full Text] [Related]

  • 3. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G.
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine-induced renal dysfunction.
    Paul LC, de Fijter JH.
    Transplant Proc; 2004 Mar; 36(2 Suppl):224S-228S. PubMed ID: 15041342
    [Abstract] [Full Text] [Related]

  • 5. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X, Johnston A.
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [Abstract] [Full Text] [Related]

  • 6. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
    Kahan BD.
    Transplantation; 2001 Jun 15; 71(11 Suppl):SS52-7. PubMed ID: 11583490
    [Abstract] [Full Text] [Related]

  • 7. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 15; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 8. Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation.
    Lewis RM.
    Kidney Int Suppl; 1995 Dec 15; 52():S75-8. PubMed ID: 8587289
    [Abstract] [Full Text] [Related]

  • 9. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
    Zürcher RM, Bock HA, Thiel G.
    Nephrol Dial Transplant; 1996 Jan 15; 11(1):153-8. PubMed ID: 8649625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
    Morozumi K, Takeda A, Uchida K, Mihatsch MJ.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):251S-256S. PubMed ID: 15041348
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.
    Clin Transplant; 2005 Oct 15; 19(5):683-9. PubMed ID: 16146562
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J, Jalanko H, Leijala M, Sairanen H, Holmberg C.
    J Heart Lung Transplant; 1997 Dec 15; 16(12):1217-24. PubMed ID: 9436133
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant.
    Perico N, Detcheva A, Khalil EI, Remuzzi G.
    Kidney Int; 1996 May 15; 49(5):1283-8. PubMed ID: 8731092
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
    Baboolal K.
    Transplantation; 2003 Apr 27; 75(8):1404-8. PubMed ID: 12717239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.